{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:54:01Z","timestamp":1782442441074,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Breastfeed J"],"DOI":"10.1186\/s13006-025-00775-9","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:27:25Z","timestamp":1767025645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enzyme replacement therapy during pregnancy and breastfeeding in late-onset Pompe disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Magdalena","family":"Bachmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholl-B\u00fcrgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Margreitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Karall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Z\u00f6ggeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"12","key":"775_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00115-013-3947-9","volume":"84","author":"A Sch\u00fcller","year":"2013","unstructured":"Sch\u00fcller A, Kornblum C, Deschauer M, Vorgerd M, Schrank B, Mengel E, et al. Diagnosis and therapy of late onset pompe disease. Nervenarzt. 2013;84(12):1467\u201372.","journal-title":"Nervenarzt"},{"issue":"15","key":"775_CR2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"van der Ploeg At","year":"2010","unstructured":"van der Ploeg At, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, et al. A randomized study of alglucosidase alfa in late-onset pompe\u2019s disease. N Engl J Med. 2010;362(15):1396\u2013406.","journal-title":"N Engl J Med"},{"issue":"1\u201302","key":"775_CR3","first-page":"33","volume":"92","author":"P Hahn","year":"2024","unstructured":"Hahn P, Siefen RG, Benz K, Jackowski J, K\u00f6hler C, L\u00fccke T. Diagnosis and management of late-onset pompe disease. Fortschr Neurol Psychiatr. 2024;92(1\u201302):33\u201340.","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"775_CR4","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.ymgme.2024.108590","volume":"143","author":"KA George","year":"2024","unstructured":"George KA, Anding AL, van der Flier A, Tomassy GS, Berger KI, Zhang TY, et al. Pompe disease: unmet needs and emerging therapies. Mol Genet Metab. 2024;143(3):108590.","journal-title":"Mol Genet Metab"},{"key":"775_CR5","unstructured":"Sanofi BV. Summary of product characteristics. Report No.: eU\/1\/06\/333\/001-003. 2006, Myozyme Amsterdam (NL)."},{"issue":"4","key":"775_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ymgme.2011.09.012","volume":"104","author":"de Vries Jm","year":"2011","unstructured":"de Vries Jm, Brugma JD, Ozkan L, Steegers EA, Reuser AJ, van Doorn Pa, et al. First experience with enzyme replacement therapy during pregnancy and lactation in pompe disease. Mol Genet Metab. 2011;104(4):552\u201355.","journal-title":"Mol Genet Metab"},{"key":"775_CR7","unstructured":"Drugs and Lactation Database (LactMed\u00ae). Alglucosidase alfa. Bethesda (MD): National Institute of Child Health and Human Development. 2006 [updated 2024 Oct 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501820 ."},{"key":"775_CR8","unstructured":"Drugs and Lactation Database (LactMed\u00ae). Avalglucosidase Alfa. Bethesda (MD): Bethesda (MD): National Institute of Child Health and Human Development: National Institute of Child Health and Human Development; 2006 [updated 2023 Nov 15.]"},{"key":"775_CR9","doi-asserted-by":"crossref","unstructured":"Goker-Alpan O, Kasturi VG, Sohi MK, Limgala RP, Austin SL, Jennelle T, et al. Pregnancy outcomes in late onset pompe disease. Life (Basel). 2020;10(9).","DOI":"10.3390\/life10090194"},{"issue":"10","key":"775_CR10","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.nmd.2017.06.556","volume":"27","author":"M Holbeck-Brendel","year":"2017","unstructured":"Holbeck-Brendel M, Poulsen BK. Treatment with enzyme replacement therapy during pregnancy in a patient with pompe disease. Neuromuscul Disord. 2017;27(10):956\u201358.","journal-title":"Neuromuscul Disord"},{"issue":"9\u201310","key":"775_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.18071\/ISZ.73.0339","volume":"73","author":"Z Grosz","year":"2020","unstructured":"Grosz Z, V\u00e1rdi KV, Moln\u00e1r JM. Pompe disease treated with enzyme replacement therapy in pregnancy. Ideggyogy Sz. 2020;73(9\u201310):339\u201344.","journal-title":"Ideggyogy Sz"},{"issue":"1","key":"775_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13760-019-01089-4","volume":"119","author":"J Van Houtte","year":"2019","unstructured":"Van Houtte J, De Bleecker JL. Two successfully completed pregnancies in adult onset pompe disease, under continued treatment with alglucosidase alfa. Acta Neurol Belg. 2019;119(1):147\u201349.","journal-title":"Acta Neurol Belg"},{"issue":"11","key":"775_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.nmd.2018.08.002","volume":"28","author":"M Oliveira Santos","year":"2018","unstructured":"Oliveira Santos M, Evangelista T, I C. Enzyme replacement therapy with alglucosidase alfa in a late-onset pompe disease patient during pregnancy. Neuromuscul Disord. 2018;28(11):965\u201368.","journal-title":"Neuromuscul Disord"},{"key":"775_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2017.01.068","volume":"375","author":"J K\u0142os","year":"2017","unstructured":"K\u0142os J, Kwa\u015bniak-Butowska M, S\u0142awek J. Alglucosidase alfa therapy for pompe disease in pregnancy - case report. J Neurol Sci. 2017;375:167\u201369.","journal-title":"J Neurol Sci"},{"key":"775_CR15","doi-asserted-by":"crossref","unstructured":"Nampoothiri S, Yesodharan D, Kuthiroly S, Puthenveettil N, Murali V, Peethambaran P, et al. Successful pregnancy outcome in a patient with pompe disease receiving enzyme replacement therapy: a case report and review of the literature. Archiv Clin And Med Case Rep. 2022;06.","DOI":"10.26502\/acmcr.96550461"},{"key":"775_CR16","volume-title":"WHO child growth standards : length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age : methods and development","author":"O Md","year":"2006","unstructured":"Onis Md. WHO child growth standards : length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age : methods and development. Geneva: World Health Organization (NFS); 2006."},{"key":"775_CR17","unstructured":"Group WMGRS. WHO child growth standards. Acta Paediatrica. 2006;1\u2013104"},{"key":"775_CR18","volume-title":"WHO child growth standards: head circumference-for-age, arm circumference-for-age, triceps skinfold-for-age and subscapular skinfold-for-age: methods and development","author":"O Md","year":"2007","unstructured":"Onis Md. WHO child growth standards: head circumference-for-age, arm circumference-for-age, triceps skinfold-for-age and subscapular skinfold-for-age: methods and development. Geneva: World Health Organization (NFS); 2007."},{"issue":"9","key":"775_CR19","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1373\/clinchem.2011.164640","volume":"57","author":"TF Metz","year":"2011","unstructured":"Metz TF, Mechtler TP, Orsini JJ, Martin M, Shushan B, Herman JL, et al. Simplified newborn screening protocol for lysosomal storage disorders. Clin Chem. 2011;57(9):1286\u201394.","journal-title":"Clin Chem"},{"issue":"4","key":"775_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20019","volume":"55","author":"LP Winkel","year":"2004","unstructured":"Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, et al. Enzyme replacement therapy in late-onset pompe\u2019s disease: a three-year follow-up. Ann Neurol. 2004;55(4):495\u2013502.","journal-title":"Ann Neurol"},{"issue":"2","key":"775_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/jpem-2021-0465","volume":"35","author":"T Z\u00f6ggeler","year":"2022","unstructured":"Z\u00f6ggeler T, Ramoser G, H\u00f6ller A, J\u00f6rg-Streller M, Janzen N, Ramoni A, et al. Nitisinone treatment during two pregnancies and breastfeeding in a woman with tyrosinemia type 1 - a case report. J Pediatr Endocrinol Metab. 2022;35(2):259\u201365.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"775_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S0002-9378(97)70099-1","volume":"177","author":"D Elstein","year":"1997","unstructured":"Elstein D, Granovsky-Grisaru S, Rabinowitz R, Kanai R, Abrahamov A, Zimran A. Use of enzyme replacement therapy for gaucher disease during pregnancy. Am J Obstet Gynecol. 1997;177(6):1509\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"775_CR23","first-page":"53","volume":"16","author":"SR Giannubilo","year":"2015","unstructured":"Giannubilo SR, Pasculli A, Tidu E, Ciavattini A. Replacement therapy for gaucher disease during pregnancy: a case report. J Reprod Infertil. 2015;16(1):53\u201357.","journal-title":"J Reprod Infertil"},{"issue":"1","key":"775_CR24","first-page":"76","volume":"57","author":"E Lukina","year":"2021","unstructured":"Lukina E, Balwani M, Belmatoug N, Watman N, Hughes D, Gaemers SJM, et al. Pregnancy outcome in women with gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials. JIMD Rep. 2021;57(1):76\u201384.","journal-title":"JIMD Rep"},{"issue":"10","key":"775_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/jog.13055","volume":"42","author":"PJ Rohman","year":"2016","unstructured":"Rohman PJ, Scott E, Richfield L, Ramaswami U, Hughes DA. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (pompe disease). J Obstet Gynaecol Res. 2016;42(10):1263\u201371.","journal-title":"J Obstet Gynaecol Res"},{"key":"775_CR26","doi-asserted-by":"crossref","unstructured":"Yanagihara C, Hayasaka Y, Kageyama Y. Pregnancy during enzyme replacement therapy with alglucosidase alfa over a 14-year period in late-onset pompe disease. Neurol And Clin Neuroscience2023. 97\u201399.","DOI":"10.1111\/ncn3.12695"},{"key":"775_CR27","unstructured":"(LactMed\u00ae) DaLD. Cipaglucosidase alfa. Bethesda (MD): National Institute of Child Health and Human Development. 2006 [updated 2023 Nov 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK596280\/ ."},{"key":"775_CR28","volume-title":"Arzneimittel in Schwangerschaft und Stillzeit 8ed","author":"C Schaefer","year":"2011","unstructured":"Schaefer C, Spielmann H, Vetter K, Weber-Sch\u00f6ndorfer C. Arzneimittel in Schwangerschaft und Stillzeit 8ed. Deutschland: Urban & Fischer in Elsevier; 2011."},{"issue":"12","key":"775_CR29","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.clinthera.2010.11.008","volume":"32","author":"Y Sekijima","year":"2010","unstructured":"Sekijima Y, Ohashi T, Ohira S, Kosho T, Fukushima Y. Successful pregnancy and lactation outcome in a patient with gaucher disease receiving enzyme replacement therapy, and the subsequent distribution and excretion of imiglucerase in human breast milk. Clin Ther. 2010;32(12):2048\u201352.","journal-title":"Clin Ther"},{"key":"775_CR30","volume-title":"A guide for the medical profession","author":"RA Lawrence","year":"2022","unstructured":"Lawrence RA, Breastfeeding LR. A guide for the medical profession. 9. Philadelphia: Elsevier; 2022.","edition":"9"},{"issue":"1","key":"775_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1010539515624964","volume":"28","author":"C Binns","year":"2016","unstructured":"Binns C, Lee M, Low WY. The long-term public health benefits of breastfeeding. Asia Pac J Public Health. 2016;28(1):7\u201314.","journal-title":"Asia Pac J Public Health"},{"issue":"6","key":"775_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00112-020-00911-1","volume":"168","author":"D Karall","year":"2020","unstructured":"Karall D, Nindl G, Zittera I, Bier A, von der Ohe G, Gu\u00f3th-Gumberger M, et al. Stillen und stillberatung. Monatsschr Kinderheilkunde. 2020;168(6):547\u201360.","journal-title":"Monatsschr Kinderheilkunde"}],"container-title":["International Breastfeeding Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13006-025-00775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13006-025-00775-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13006-025-00775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:27:27Z","timestamp":1767025647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13006-025-00775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s13006-025-00775-9","relation":{},"ISSN":["1746-4358"],"issn-type":[{"value":"1746-4358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board (IRB) of the Medical University of Innsbruck (Approval Number: 1195\/2023, Date of Approval: 2023\u201308-23). Written informed consent was obtained from all participants (or their legal guardians, if applicable) prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants (or their legal guardians, if applicable).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}